VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.39
−0.57%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+32.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2026 | Coughlin Timothy · director | A-Award | 8,000 | $0.00 |
| Jun 10, 2026 | Coughlin Timothy · director | A-Award | 16,000 | $8.51 |
| Jun 2, 2026 | Sabatini Brent · officer: SVP, Chief Accounting Officer | Sale | 379 | $9.45 |
| Jun 2, 2026 | Napolitano Janet · director | Sale | 3,200 | $9.45 |
| May 28, 2026 | Sigal Charles Elliott · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | Sigal Charles Elliott · director | A-Award | 8,000 | $0.00 |
| May 28, 2026 | Napolitano Janet · director | A-Award | 8,000 | $0.00 |
| May 28, 2026 | BISCHOFBERGER NORBERT W · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | MORE ROBERT J · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | Napolitano Janet · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | Hatfield Jeffrey S. · director | A-Award | 8,000 | $0.00 |
| May 28, 2026 | Farid Ramy · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | Hatfield Jeffrey S. · director | A-Award | 16,000 | $9.10 |
| May 28, 2026 | MORE ROBERT J · director | A-Award | 8,000 | $0.00 |
| May 28, 2026 | BISCHOFBERGER NORBERT W · director | A-Award | 8,000 | $0.00 |
| May 28, 2026 | Farid Ramy · director | A-Award | 8,000 | $0.00 |
| May 4, 2026 | SATO VICKI L · director | Sale | 22,000 | $10 |
| Apr 7, 2026 | De Backer Marianne · director, officer: President and CEO | Sale | 72,559 | $9.16 |
| Apr 2, 2026 | SATO VICKI L · director | Sale | 22,000 | $9.07 |
| Mar 24, 2026 | Sabatini Brent · officer: SVP, Chief Accounting Officer | Sale | 7,711 | $9.12 |
| Feb 26, 2026 | SATO VICKI L · director | Sale | 200 | $10 |
| Feb 26, 2026 | Eisner Mark · officer: EVP and Chief Medical Officer | Sale | 1,889 | $9.82 |
| Feb 26, 2026 | de Verneuil Vanina · officer: EVP, General Counsel, Corp Sec | Sale | 3,117 | $9.53 |
| Feb 26, 2026 | SATO VICKI L · director | Sale | 42,177 | $9.75 |
| Feb 26, 2026 | Eisner Mark · officer: EVP and Chief Medical Officer | Sale | 1,616 | $9.53 |
| Feb 26, 2026 | Sabatini Brent · officer: SVP, Chief Accounting Officer | Sale | 1,430 | $9.53 |
| Feb 26, 2026 | SATO VICKI L · director | M-Exempt | 42,377 | $1.49 |
| Feb 26, 2026 | O'Byrne Jason · officer: EVP & Chief Financial Officer | Sale | 1,634 | $9.53 |
| Feb 26, 2026 | de Verneuil Vanina · officer: EVP, General Counsel, Corp Sec | Sale | 13,700 | $9.82 |
| Feb 26, 2026 | De Backer Marianne · director, officer: Chief Executive Officer | Sale | 14,762 | $9.53 |
Institutional positioning
13F filings over the trailing two quarters
New 101Increased 213Reduced 124Sold out 45
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 20,678,283 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 17,998,329 | May 13, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 12,916,663 | May 15, 2026 |
| ARCH Venture Management, LLC | Reduced | 12,694,163 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 11,495,215 | Aug 13, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 10,948,093 | Aug 14, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Reduced | 10,948,093 | May 18, 2026 |
| STATE STREET CORP | Increased | 9,964,151 | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 9,215,577 | May 8, 2026 |
| GSK plc | Unchanged | 8,550,954 | Aug 13, 2026 |
| GSK PLC | Unchanged | 8,550,954 | May 14, 2026 |
| STATE STREET CORP | Increased | 7,141,094 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6,388,775 | Aug 13, 2026 |
| Point72 Asset Management, L.P. | Increased | 5,666,821 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,382,103 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2026